NeoGenomics
280 hedge funds and large institutions have $1.34B invested in NeoGenomics in 2022 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 86 increasing their positions, 98 reducing their positions, and 71 closing their positions.
38% more call options, than puts
Call options by funds: $4.4M | Put options by funds: $3.2M
5.73% less ownership
Funds ownership: 95.72% → 89.99% (-5.7%)
9% less funds holding
Funds holding: 309 → 280 (-29)
12% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 98
31% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 71
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less capital invested
Capital invested by funds: $4.02B → $1.34B (-$2.68B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$21.6M |
| 2 |
Two Sigma Investments
New York
|
+$18M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$12.8M |
| 4 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
+$12.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$55.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$51M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$24.1M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$22.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$21.1M |
NEO Hedge Fund Activity: Q1 2022 in Review
280 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2022, worth a combined $1.34B — down 67% from $4.02B a quarter earlier.
Sellers outnumbered buyers: 71 funds closed out of NEO and 49 opened new positions — a net loss of 22 holders — while 98 trimmed existing stakes and 86 added.
The largest buyer was Brown Advisory, adding an estimated $21.6M. The largest seller was Artisan Partners, cutting an estimated $55.6M.
- 280 institutional investors held NeoGenomics (NEO) as of Q1 2022, down from 309 in Q4 2021.
- Funds reported $1.34B of NeoGenomics stock for Q1 2022, down 67% quarter-over-quarter.
- 49 funds opened new NeoGenomics positions in Q1 2022 and 71 closed out, a net change of -22 holders.
- The largest NeoGenomics buyer in Q1 2022 was Brown Advisory, an estimated $21.6M added.
- The largest NeoGenomics seller in Q1 2022 was Artisan Partners, an estimated $55.6M sold.
Based on aggregated 13F filings for Q1 2022.